Flputnam Investment Management Co. Invests $13.15 Million in Danaher Corporation $DHR

Flputnam Investment Management Co. purchased a new position in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 18,265 shares of the conglomerate’s stock, valued at approximately $13,152,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. High Note Wealth LLC increased its position in Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the last quarter. First Command Advisory Services Inc. lifted its position in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares during the last quarter. GW&K Investment Management LLC grew its stake in shares of Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after acquiring an additional 47 shares during the period. Kestra Private Wealth Services LLC increased its holdings in Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after acquiring an additional 48 shares during the last quarter. Finally, SOL Capital Management CO increased its holdings in Danaher by 2.7% in the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after acquiring an additional 50 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE:DHR opened at $202.51 on Monday. The company has a 50 day moving average of $193.14 and a 200 day moving average of $192.91. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $142.37 billion, a P/E ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 EPS. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DHR has been the topic of several recent research reports. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Morgan Stanley reduced their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. lowered their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, TD Cowen cut their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Check Out Our Latest Stock Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.